Background: The effects of continuous positive airway pressure (CPAP) treatment on the function of the lower airways are poorly understood. One of the methods used to determine the influence of positive pressure breathing on lower airways is the bronchial hyperreactivity test. Some authors report that CPAP increases bronchial hyperreactivity, while others report decreases. Objectives: To assess the influence of CPAP treatment on bronchial reactivity and the effects of bronchial hyperreactivity on compliance to CPAP treatment. Methods: The study group consisted of 101 obstructive sleep apnea syndrome patients (88 men and 13 women) with a mean age of 51 ± 11 years, mean apnea-hypopnea index of 53 ± 20 and mean body mass index of 32.6 ± 5.4. Patients were randomly assigned to a treatment group that received 3 weeks of CPAP therapy (group 1) or to a nontreatment control group (group 2). Pulmonary function tests and the methacholine bronchial provocation test were performed at baseline and 3 weeks later. Results: There were no statistically significant differences between treated and control groups in anthropometry and polysomnography variables. At baseline, bronchial hyperreactivity was found in 6 patients from group 1 and 5 patients from group 2. A significant increase in bronchial reactivity was observed after CPAP treatment. Log PC20M decreased from 1.38 ± 0.30 at baseline to 1.26 ± 0.50 (p < 0.05). In group 2, changes were statistically insignificant. Patients with bronchial hyperreactivity during CPAP treatment were characterized by significantly lower FEV1, FVC and MEF50 values. Conclusions: CPAP produces statistically significant bronchial hyperreactivity. However, there were no clinical symptoms and it is not necessary to withdraw previous therapies.

Keywords:
Obstructive sleep apnea, Continuous positive airway pressure, Bronchial hyperreactivity
1.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230–1235.
2.
McNicholas WT, Bonsigore MR, Management Committee of EU COST ACTION B26: Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156–178.
3.
Sullivan CE, Issa FG, Berthon-Jones M, Eves L: Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981;i:862–865.
4.
Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944. Am J Respir Crit Care Med 1994;150:1738–1745.
5.
Pepin JL, Leger P, Veale D, Langevin B, Robert D, Levy P: Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 1995;107:375–381.
6.
Wenzel G, Schonhofer B, Wenzel M, Kohler D: Bronchial hyperreactivity and nCPAP therapy (in German). Pneumologie 1997;51:770–772.
7.
Lin CC, Lin CY: Obstructive sleep apnea syndrome and bronchial hyperreactivity. Lung 1995;173:117–126.
8.
Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee: Practice parameters for the indications for polysomnography and related procedures. Sleep 1997;20:406–422.
9.
Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles, UCLA Brain Information Service/Brain Research Institute, 1968.
10.
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107–1136.
11.
Coates AL, Peslin R, Rodenstein D, Stocks J: Measurement of lung volumes by plethysmography. Eur Respir J 1997;10:1415–1427.
12.
Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ: Guidelines for methacholine and exercise challenge testing – 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309–329.
13.
Fietze I, Glos M, Moebus I, Witt C, Penzel T, Baumann G: Automatic pressure titration with APAP is as effective as manual titration with CPAP in patients with obstructive sleep apnea. Respiration 2007;74:279–286.
14.
Brown R, Mitzner W: Airway response to deep inspiration: role of inflation pressure. J Appl Physiol 2001;91:2574–2578.
15.
Devouassoux G, Levy P, Rossini E, Pin I, Fior-Gozlan M, Henry M, Seigneurin D, Pepin JL: Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness. J Allergy Clin Immunol 2007;119;597–603.
16.
Dorow P, Thalhofer S, Meissner P, Heinemann S: The effect of nCPAP respiration on hyperreactivity in patients with sleep related respiratory disorder (in German). Pneumologie 1995;49:136–138.
17.
Thalhofer S, Dorow P, Meissner P, Luding K: Change in bronchial hyperreactivity with nCPAP respiration in patients with sleep related respiratory disorders (in German). Pneumologie 1997;51:767–769.
18.
Lafond C, Series F, Lemiere C: Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J 2007;29:307–311.
19.
Kaufman J, Wright G: The effect of nasal and nasopharyngeal irritation on airway resistance in man. Am Rev Respir Dis 1969;100:626–630.
20.
Friberg D, Ansved T, Borg K, Carlsson-Nordlander B, Larsson H, Svanborg E: Histological indications of a progressive snorers disease in an upper airway muscle. Am J Respir Crit Care Med 1998;157:586–593.
21.
Britton J, Pavord I, Richards K, Knox A, Wisniewski A, Wahedna I, Kinnear W, Tattersfield A, Weiss S: Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibre. Eur Respir J 1994;7:881–887.
22.
Hopp RJ, Bewtra A, Nair NM, Townley RG: The effect of age on methacholine response. J Allergy Clin Immunol 1985;76:609–613.
23.
Sparrow D, O’Connor GT, Rosner B, Segal MR, Weiss ST: The influence of age and level of pulmonary function on nonspecific airway responsiveness. The Normative Aging Study. Am Rev Respir Dis 1991;143:978–982.
24.
Burney PG, Britton JR, Chinn S, Tattersfield AE, Papacosta AO, Kelson MC, Anderson F, Corfield DR: Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax 1987;42:38–44.
25.
Amin K, Ekberg-Jansson A, Lofdahl CG, Venge P: Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study. Thorax 2003;58:135–142.
26.
Dinges DF, Kribbs NB, Schwartz AR, Smith PL, Pack AI: Objective measurement of nasal continuous positive airway pressure use: ethical considerations. Am J Respir Crit Care Med 1994;149:291–292.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.